돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1070593생성일: 2026년 10월 26일

Aminoguanidine → [1,2,3]Thiadiazolo[5,4-d]pyrimidine

https://huagongshe.com/reaction/1070593

반응식

참여 물질

역할이름HCID투입량
반응물AminoguanidineHCID 2146—
반응물Diethyl (ethoxymethylene)malonateHCID 6871—
반응물1,2,3-ThiadiazoleHCID 67518—
반응물(4-Morpholinyl)acetic acid trifluoroacetic acid saltHCID 69732510—
생성물[1,2,3]Thiadiazolo[5,4-d]pyrimidineHCID 45080540—

반응 단계

5-Hydroxy-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidine-6-carboxamides. As described in Chart BL, (4-morpholinyl)acetic acid trifluoroacetic acid salt BL.1 (J. Med. Chem. 1994, 37, 4538-4554) is cyclized to the thiadiazole BL.2 with aminoguanidine in polyphosphoric acid. Condensation of BL.2 with diethyl ethoxymethylenemalonate followed by thermal cyclization affords thiadiazolopyrimidine BL.3. The resulting ester BL.3 is then saponified to afford the corresponding acid BL.4 which is then coupled with a benzylamine (e.g. 4-chlorobenzylamine) mediated by 1,1′-carbonyldiimidazole (or other suitable carboxylic acid activating agent) to provide amides of the general formula BL.5. A specific example of heterocycle W19.2 in which R8=OH is also prepared as described in Chart BL. Thiadiazole BL.2 is heated in xylenes with diethyl 2-(((4-chlorobenzyl)amino)carbonyl)malonate (prepared by the reaction of 4-chlorobenzylamine with triethyl methanetricarboxylate) to afford thiadiazolopyrimidine BL.6.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06903097B2
출처 데이터셋uspto-grants-2005_06
ORD IDord-e0b8b46c4f1c47d6a76a2bff9286f9c8
출처 메모uspto-grants-2005_06